Ono, Ayami
Tanaka, Shiori
Sawada, Norie
Goto, Atsushi
Tsugane, Shoichiro
Muraki, Isao
Yamagishi, Kazumasa
Sasaki, Yu
Abe, Yasuhiko
Kayama, Takamasa
Ueno, Yoshiyuki
Saito, Eiko
Yamaji, Taiki
Iwasaki, Motoki
Inoue, Manami
Funding for this research was provided by:
National Cancer Center Research and Development Fund (23-A-31(toku), 26-A-2, 29-A-4, 23-A-31(toku), 26-A-2, 29-A-4)
Research and Development by the Ministry of Education, Culture, Sports, Science, and Technology of Japan
the Japan Society for the Promotion of Science KAKENHI (JP20K08350)
Japan Agency for Medical Research and Developmen (17ck0106277h0001,18ck0106277h0002,19ck0106277h0003,20ck0106561h0001,20ck0106561h0001RR,21ck0106561h0002,21ck0106561h0002RR,22ck0106561h0003, 22ck0106561h0003RR)
Article History
Received: 5 September 2024
Accepted: 30 April 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no conflicts of interest.
: The study was conducted conforming to the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects and was initiated in each cohort by obtaining written informed consent from all participants at the time of study enrollment. The individual study protocols were approved by the Institutional Review Board of Yamagata University Faculty of Medicine (#2019–175) and the National Cancer Center Japan (2011–186), and the pooled analysis protocol was approved by Yamagata University Faculty of Medicine (#2019–175) and the National Cancer Center Japan (2017–243).